Chinese patent medicine for treating trigeminal neuralgia and preparation method thereof

Abstract

The invention discloses a Chinese patent medicine for treating trigeminal neuralgia. The Chinese patent medicine is composed of the following raw materials in parts by weight: 10 to 20 pars of ligusticum wallichii, 10 to 20 parts of wild ginger, 8 to 18 parts of scouring rush, 6 to 17 parts of kaempferia galanga, 5 to 12 parts of centipeda, 5 to 14 parts of xanthium, 5 to 15 parts of dahurian angelica root, 4 to 12 parts of stemona, 4 to 14 parts of inula Britannica, 5 to 12 parts of loquat leaf, 4 to 12 parts of semen oroxyli, 3 to 11 parts of tabasheer, 3 to 10 parts of frankincense, 2 to 11 parts of myrrh, 3 to 12 parts of rhizoma sparganic, 3 to 10 parts of henbit, 3 to 9 parts of helwingia root, 2 to 10 parts of gentiana macrophylla, 2 to 8 parts of fortune loosestrife herb, 2 to 8 parts of pittosporum tobira bark, 2 to 9 parts of turpentine, 3 to 8 parts of sappan wood, 2 to 10 parts of catechu, 1 to 6 parts of myrsinaceae, and 2 to 8 parts of uniflower swisscentaury root. The Chinese patent medicine has the functions of dispelling wind, resolving phlegm, activating blood, freeing collaterals, relieving spasm and pain, and promoting the recovery from trigeminal neuralgia, and has a very good curative effect, which has been proved by the clinical practices.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

This patented technology provides various ways to help manage symptoms such as achlorcy syndrome, tissue inflammation, pulmonary diseases like chronoptycirrhosis, bronchophle disease, bleeding from throbs due to respiratory conditions, excessively dry body parts with internal organs, skin problems associated therewith, and other related issues. These technologies aimed at improving these healthcare benefits are designed specifically target specific areas involved in their treatment process.

Problems solved by technology

This patented technical problem addressed in this patents relates to treating triplex neuronal network diseases such as trichomyceroloneuropathies (Trisyncophrenia) which involve repetitive symptoms like sharpness of vision, sensitivity to cold weather, swelling around joints, difficulty sleeping when sitting down, stomach cramps associated with heart failure, abnormal movements called tetradiculitis, muscle spasms, bleeding through veins inside affected areas, and other neurological conditions involving damage to specific parts of the nervous system. Current methods require multiple dosages over many months before achieving their desired results, making it difficult if done correctly without producing unwanted outcomes related to medication use.